All Phenotypes Slc1a3<tm1(cre/ERT2)Mgoe> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Slc1a3^{tm1(cre/ERT2)Mgoe}
targeted mutation 1, Magdalena Goetz
MGI:3830051

Summary

4 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor^tm1Sor Pten^tm1Mro/Pten^tm1Mro Slc1a3^{tm1(cre/ERT2)Mgoe}/Slc1a3⁺ Trp53^tm1Brn/Trp53^tm1Brn	involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor	MGI:5790976
cn2	Ntrk2^tm2Kln/Ntrk2^tm2Kln Slc1a3^{tm1(cre/ERT2)Mgoe}/? Gt(ROSA)26Sor^tm1Sor/?	involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * SJL	MGI:3830091
cn3	Chd7^{tm2c(EUCOMM)Wtsi}/Chd7^{tm2c(EUCOMM)Wtsi} Slc1a3^{tm1(cre/ERT2)Mgoe}/Slc1a3⁺	involves: 129S2/SvPas * C57BL/6 * C57BL/6N * SJL	MGI:7496108
cn4	Ntrk2^tm2Kln/Ntrk2^tm2Kln Slc1a3^{tm1(cre/ERT2)Mgoe}/? Tg(CAG-Bgeo/GFP)21Lbe/?	involves: 129/Sv * C57BL/6 * SJL	MGI:3830092

Allelic Composition	Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor^tm1Sor Pten^tm1Mro/Pten^tm1Mro Slc1a3^{tm1(cre/ERT2)Mgoe}/Slc1a3⁺ Trp53^tm1Brn/Trp53^tm1Brn
Genetic Background	involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^tm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (994 available)
Pten^tm1Mro mutation (1 available); any Pten mutation (88 available)
Slc1a3^{tm1(cre/ERT2)Mgoe} mutation (0 available); any Slc1a3 mutation (70 available)
Trp53^tm1Brn mutation (18 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased glioma incidence ( J:229481 )

• 3 of 16 mice injected with endoxifen develop glial tumors with lesions of different sizes and varying extents of infiltration

• small neoplastic lesions in endoxifen-induced mice arise from beneath the SVZ and extend into the striatum and dorsally into the corpus callosum

• larger tumors of endoxifen-induced mice show expansion into and a diffuse infiltration of the entire caudate nucleus

• some tumors contain areas of necrosis and occasional microvascular proliferations similar to those in malignant gliomas

increased astrocytoma incidence ( J:229481 )

• endoxifen-induced tumors show glial morphology with features typical of astrocytomas and oligodendrogliomas

increased oligodendroglioma incidence ( J:229481 )

• endoxifen-induced tumors show glial morphology with features typical of astrocytomas and oligodendrogliomas

nervous system

increased glioma incidence ( J:229481 )

• 3 of 16 mice injected with endoxifen develop glial tumors with lesions of different sizes and varying extents of infiltration

• small neoplastic lesions in endoxifen-induced mice arise from beneath the SVZ and extend into the striatum and dorsally into the corpus callosum

• larger tumors of endoxifen-induced mice show expansion into and a diffuse infiltration of the entire caudate nucleus

• some tumors contain areas of necrosis and occasional microvascular proliferations similar to those in malignant gliomas

increased astrocytoma incidence ( J:229481 )

• endoxifen-induced tumors show glial morphology with features typical of astrocytomas and oligodendrogliomas

increased oligodendroglioma incidence ( J:229481 )

• endoxifen-induced tumors show glial morphology with features typical of astrocytomas and oligodendrogliomas

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
high grade glioma		DOID:3070	OMIM:PS137800	J:229481

Allelic Composition	Ntrk2^tm2Kln/Ntrk2^tm2Kln Slc1a3^{tm1(cre/ERT2)Mgoe}/? Gt(ROSA)26Sor^tm1Sor/?
Genetic Background	involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^tm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (994 available)
Ntrk2^tm2Kln mutation (0 available); any Ntrk2 mutation (66 available)
Slc1a3^{tm1(cre/ERT2)Mgoe} mutation (0 available); any Slc1a3 mutation (70 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

abnormal neuron differentiation ( J:143452 )

• fewer neurons arising in hippocampus from radial glial cells after treatment with tamoxifen survive to become mature neurons

• axon elongation is unaffected

abnormal dendrite morphology ( J:143452 )

• dendritic branching and lengths are reduced in neurons arising in the hippocampus from radial glial cells after treatment with tamoxifen

• reduced dendritic complexity 90 um from soma

• spine density is significantly reduced

reduced long-term potentiation ( J:143452 )

• lasts only 30-40 minutes as compared to over 90 minutes for controls

behavior/neurological

increased thigmotaxis ( J:143452 )

• studied between 28 and 42 days after tamoxifen treatment

• enter the center in an open field test less frequently and spend less time there

• more time spent on the periphery in an open field test

• in an elevated + maze, fewer entries into the open arms and less time spent in the open arms

decreased locomotor activity ( J:143452 )

• studied between 28 and 42 days after tamoxifen treatment

• less spontaneous activity in an open field test

cellular

abnormal neuron differentiation ( J:143452 )

• fewer neurons arising in hippocampus from radial glial cells after treatment with tamoxifen survive to become mature neurons

• axon elongation is unaffected

Allelic Composition	Chd7^{tm2c(EUCOMM)Wtsi}/Chd7^{tm2c(EUCOMM)Wtsi} Slc1a3^{tm1(cre/ERT2)Mgoe}/Slc1a3⁺
Genetic Background	involves: 129S2/SvPas * C57BL/6 * C57BL/6N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chd7^{tm2c(EUCOMM)Wtsi} mutation (0 available); any Chd7 mutation (138 available)
Slc1a3^{tm1(cre/ERT2)Mgoe} mutation (0 available); any Slc1a3 mutation (70 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

increased neuron apoptosis ( J:222062 )

• in the hippocampus at 12 weeks after tamoxifen treatment

abnormal neuronal stem cell morphology ( J:222062 )

• at 8 months after tamoxifen injection there is a significant depletion of neuronal stem cells

abnormal neuron number ( J:222062 )

decreased neuronal precursor cell number ( J:222062 )

• at 12 weeks after tamoxifen treatment a significant decrease in the number of neuronal progenitors and immature neurons

increased neuronal precursor cell number ( J:222062 )

• increase in the number of progenitors and immature neurons 4 weeks after tamoxifen injection

• at 12 weeks after tamoxifen treatment radial neuronal stem cells numbers are increased almost 3-fold and the number of proliferating radial neuronal stem cells is increased over 2-fold

decreased neuron number ( J:222062 )

• at 12 weeks and 8 months after tamoxifen treatment a significant decrease in the number of neuronal progenitors and immature neurons is seen

increased neuron number ( J:222062 )

• increase in the number of progenitors and immature neurons 4 weeks after tamoxifen injection

increased neuronal stem cell self-renewal ( J:222062 )

• increase in proliferation in the subgranular zone 6-7 days after following tamoxifen injection

cellular

increased neuron apoptosis ( J:222062 )

• in the hippocampus at 12 weeks after tamoxifen treatment

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
CHARGE syndrome		DOID:0050834	OMIM:214800	J:222062

Allelic Composition	Ntrk2^tm2Kln/Ntrk2^tm2Kln Slc1a3^{tm1(cre/ERT2)Mgoe}/? Tg(CAG-Bgeo/GFP)21Lbe/?
Genetic Background	involves: 129/Sv * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ntrk2^tm2Kln mutation (0 available); any Ntrk2 mutation (66 available)
Slc1a3^{tm1(cre/ERT2)Mgoe} mutation (0 available); any Slc1a3 mutation (70 available)
Tg(CAG-Bgeo/GFP)21Lbe mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

nervous system phenotype ( J:143452 )

N	• synaptic contacts appear to be normal for neurons arising in hippocampus from radial glial cells after treatment with tamoxifen

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/17/2024 MGI 6.24